IVN Fundamental Analysis - IVISION TECH SPA

Fundamental Rating

Overall IVN gets a fundamental rating of 2 out of 10. We evaluated IVN against 65 industry peers in the Health Care Equipment & Supplies industry. IVN may be in some trouble as it scores bad on both profitability and health. IVN is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

IVN had negative earnings in the past year.

IVN had a positive operating cash flow in the past year.

1.2 Ratios

IVN has a worse Return On Assets (0.04%) than 65.57% of its industry peers.

IVN's Return On Equity of 0.13% is on the low side compared to the rest of the industry. IVN is outperformed by 65.57% of its industry peers.

With a Return On Invested Capital value of 4.89%, IVN perfoms like the industry average, outperforming 49.18% of the companies in the same industry.

IVN had an Average Return On Invested Capital over the past 3 years of 4.00%. This is significantly below the industry average of 10.04%.

The last Return On Invested Capital (4.89%) for IVN is above the 3 year average (4.00%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	0.04%
ROE	0.13%
ROIC	4.89%

ROA(3y)0.84%

ROA(5y)N/A

ROE(3y)3%

ROE(5y)N/A

ROIC(3y)4%

ROIC(5y)N/A

1.3 Margins

IVN has a worse Profit Margin (0.08%) than 65.57% of its industry peers.

IVN's Operating Margin of 8.30% is in line compared to the rest of the industry. IVN outperforms 49.18% of its industry peers.

In the last couple of years the Operating Margin of IVN has declined.

IVN has a Gross Margin (52.71%) which is in line with its industry peers.

In the last couple of years the Gross Margin of IVN has declined.

		Industry Rank	Sector Rank
OM	8.3%
PM (TTM)	0.08%
GM	52.71%

OM growth 3Y-34.07%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.35%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVN is destroying value.

IVN has more shares outstanding than it did 1 year ago.

IVN has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that IVN is in the distress zone and has some risk of bankruptcy.

IVN's Altman-Z score of 1.23 is on the low side compared to the rest of the industry. IVN is outperformed by 67.21% of its industry peers.

IVN has a debt to FCF ratio of 8.94. This is a slightly negative value and a sign of low solvency as IVN would need 8.94 years to pay back of all of its debts.

With a Debt to FCF ratio value of 8.94, IVN perfoms like the industry average, outperforming 45.90% of the companies in the same industry.

IVN has a Debt/Equity ratio of 0.64. This is a neutral value indicating IVN is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.64, IVN is doing worse than 72.13% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.64
Debt/FCF	8.94
Altman-Z	1.23

ROIC/WACC0.71

WACC6.9%

2.3 Liquidity

A Current Ratio of 1.31 indicates that IVN should not have too much problems paying its short term obligations.

IVN has a Current ratio (1.31) which is comparable to the rest of the industry.

IVN has a Quick Ratio of 1.31. This is a bad value and indicates that IVN is not financially healthy enough and could expect problems in meeting its short term obligations.

IVN's Quick ratio of 0.85 is on the low side compared to the rest of the industry. IVN is outperformed by 63.93% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.31
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.

IVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 68.42%.

Measured over the past years, IVN shows a very strong growth in Revenue. The Revenue has been growing by 87.46% on average per year.

EPS 1Y (TTM)900%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3300%

Revenue 1Y (TTM)68.42%

Revenue growth 3Y87.46%

Revenue growth 5YN/A

Sales Q2Q%41.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IVN is valued cheaply inside the industry as 90.16% of the companies are valued more expensively.

Based on the Price/Free Cash Flow ratio, IVN is valued cheaply inside the industry as 88.52% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	11.15
EV/EBITDA	6.38

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IVN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IVISION TECH SPA

BIT:IVN (1/9/2026, 7:00:00 PM)

1.675

-0.51 (-23.52%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.1%

Inst Owner ChangeN/A

Ins Owners65.71%

Ins Owner ChangeN/A

Market Cap13.25M

Revenue(TTM)17.61M

Net Income(TTM)13.30K

Analysts80

Price Target3.37 (101.19%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.75
P/FCF	11.15
P/OCF	2.98
P/B	1.32
P/tB	2.57
EV/EBITDA	6.38

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.15

FCFY8.97%

OCF(TTM)0.56

OCFY33.61%

SpS2.23

BVpS1.27

TBVpS0.65

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	0.04%
ROE	0.13%
ROCE	6.76%
ROIC	4.89%
ROICexc	5.54%
ROICexgc	7.46%
OM	8.3%
PM (TTM)	0.08%
GM	52.71%
FCFM	6.75%

ROA(3y)0.84%

ROA(5y)N/A

ROE(3y)3%

ROE(5y)N/A

ROIC(3y)4%

ROIC(5y)N/A

ROICexc(3y)4.55%

ROICexc(5y)N/A

ROICexgc(3y)5.61%

ROICexgc(5y)N/A

ROCE(3y)5.53%

ROCE(5y)N/A

ROICexgc growth 3Y-9.79%

ROICexgc growth 5YN/A

ROICexc growth 3Y-13.26%

ROICexc growth 5YN/A

OM growth 3Y-34.07%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.35%

GM growth 5YN/A

F-Score6

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	0.64
Debt/FCF	8.94
Debt/EBITDA	1.65
Cap/Depr	134.17%
Cap/Sales	18.54%
Interest Coverage	250
Cash Conversion	114.32%
Profit Quality	8932.33%
Current Ratio	1.31
Quick Ratio	0.85
Altman-Z	1.23

F-Score6

WACC6.9%

ROIC/WACC0.71

Cap/Depr(3y)136.09%

Cap/Depr(5y)N/A

Cap/Sales(3y)20.44%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)900%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3300%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)68.42%

Revenue growth 3Y87.46%

Revenue growth 5YN/A

Sales Q2Q%41.77%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y151.87%

EBIT growth 3Y23.59%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y167.31%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y672.35%

OCF growth 3YN/A

OCF growth 5YN/A

IVISION TECH SPA / IVN.MI FAQ

What is the ChartMill fundamental rating of IVISION TECH SPA (IVN.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IVN.MI.

What is the valuation status for IVN stock?

ChartMill assigns a valuation rating of 2 / 10 to IVISION TECH SPA (IVN.MI). This can be considered as Overvalued.

How profitable is IVISION TECH SPA (IVN.MI) stock?

IVISION TECH SPA (IVN.MI) has a profitability rating of 2 / 10.

IVISION TECH SPA (IVN.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

IVISION TECH SPA / IVN.MI FAQ

What is the ChartMill fundamental rating of IVISION TECH SPA (IVN.MI) stock?

What is the valuation status for IVN stock?

How profitable is IVISION TECH SPA (IVN.MI) stock?